Correlation Between AstraZeneca PLC and Mereo BioPharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both AstraZeneca PLC and Mereo BioPharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining AstraZeneca PLC and Mereo BioPharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between AstraZeneca PLC ADR and Mereo BioPharma Group, you can compare the effects of market volatilities on AstraZeneca PLC and Mereo BioPharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in AstraZeneca PLC with a short position of Mereo BioPharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of AstraZeneca PLC and Mereo BioPharma.

Diversification Opportunities for AstraZeneca PLC and Mereo BioPharma

0.72
  Correlation Coefficient

Poor diversification

The 3 months correlation between AstraZeneca and Mereo is 0.72. Overlapping area represents the amount of risk that can be diversified away by holding AstraZeneca PLC ADR and Mereo BioPharma Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mereo BioPharma Group and AstraZeneca PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on AstraZeneca PLC ADR are associated (or correlated) with Mereo BioPharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mereo BioPharma Group has no effect on the direction of AstraZeneca PLC i.e., AstraZeneca PLC and Mereo BioPharma go up and down completely randomly.

Pair Corralation between AstraZeneca PLC and Mereo BioPharma

Considering the 90-day investment horizon AstraZeneca PLC ADR is expected to generate 0.16 times more return on investment than Mereo BioPharma. However, AstraZeneca PLC ADR is 6.07 times less risky than Mereo BioPharma. It trades about 0.0 of its potential returns per unit of risk. Mereo BioPharma Group is currently generating about -0.17 per unit of risk. If you would invest  6,663  in AstraZeneca PLC ADR on October 23, 2024 and sell it today you would lose (3.00) from holding AstraZeneca PLC ADR or give up 0.05% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

AstraZeneca PLC ADR  vs.  Mereo BioPharma Group

 Performance 
       Timeline  
AstraZeneca PLC ADR 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days AstraZeneca PLC ADR has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in February 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.
Mereo BioPharma Group 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Mereo BioPharma Group has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in February 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

AstraZeneca PLC and Mereo BioPharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with AstraZeneca PLC and Mereo BioPharma

The main advantage of trading using opposite AstraZeneca PLC and Mereo BioPharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if AstraZeneca PLC position performs unexpectedly, Mereo BioPharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mereo BioPharma will offset losses from the drop in Mereo BioPharma's long position.
The idea behind AstraZeneca PLC ADR and Mereo BioPharma Group pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.

Other Complementary Tools

Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges